Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
Zongyang Lv, Kristin E. Cano, Lijia Jia, et al.
Frontiers in Chemistry (2022) Vol. 9
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.
Science Advances (2023) Vol. 9, Iss. 13
Open Access | Times Cited: 132
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 116
SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition
Sven Ullrich, Christoph Nitsche
ChemBioChem (2022) Vol. 23, Iss. 19
Open Access | Times Cited: 43
Dynamical Nonequilibrium Molecular Dynamics Simulations Identify Allosteric Sites and Positions Associated with Drug Resistance in the SARS-CoV-2 Main Protease
H. T. Henry Chan, A. Sofia F. Oliveira, Christopher J. Schofield, et al.
JACS Au (2023) Vol. 3, Iss. 6, pp. 1767-1774
Open Access | Times Cited: 30
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization
Tania Ciaglia, Vincenzo Vestuto, Veronica Di Sarno, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116128-116128
Open Access | Times Cited: 9
Predicting Antiviral Resistance Mutations in SARS-CoV-2 Main Protease with Computational and Experimental Screening
Vishnu Mini Sasi, Sven Ullrich, Jennifer Ton, et al.
Biochemistry (2022) Vol. 61, Iss. 22, pp. 2495-2505
Open Access | Times Cited: 35
Viral proteases as therapeutic targets
Taťána Majerová, Jan Konvalinka
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101159-101159
Open Access | Times Cited: 35
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
Otávio Augusto Chaves, Carlyle Ribeiro Lima, Natália Fintelman-Rodrigues, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1015-1026
Open Access | Times Cited: 29
COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage
Sumaiya Tasnim Maliha, Rabeya Fatemi, Yusha Araf
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 6
Computational evaluation and benchmark study of 342 crystallographic holo-structures of SARS-CoV-2 Mpro enzyme
Hamlet Khachatryan, Mher Matevosyan, Vardan Harutyunyan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M pro /3CL pro in Living Cells
Seyed Arad Moghadasi, Morgan A. Esler, Yuka Otsuka, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 27
Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site
Vera Jannie Elisabeth van Vliet, Nhan Huynh, Judith Palà, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 12, pp. e1011065-e1011065
Open Access | Times Cited: 23
A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2
Karen Sargsyan, Karine Mazmanian, Carmay Lim
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Furo, Pyrano, and Pyrido[2,3‐d]Pyrimidines: A Comprehensive Review of Synthesis and Medicinal Applications
Amin Rezaeifard, Mohammad Bakherad, Latifeh Navidpour, et al.
ChemistrySelect (2024) Vol. 9, Iss. 10
Closed Access | Times Cited: 5
Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape
Xinyu Wu, Margareta Go, Julie V. Nguyen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
Santo Previti, Roberta Ettari, Elsa Calcaterra, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115021-115021
Open Access | Times Cited: 19
Cryo-EM structures of Uba7 reveal the molecular basis for ISG15 activation and E1-E2 thioester transfer
Mohammad Afsar, Guanqun Liu, Lijia Jia, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Antivirals for Broader Coverage against Human Coronaviruses
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 156-156
Open Access | Times Cited: 4
Azadirachta Indica Phytoconstituents as Novel Inhibitors for Main Proteases of COVID-19: Molecular Dynamics and Simulation Study
Ubaida Hussain, Fatima Gillani, Laiba Gull, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 74-84
Closed Access
Autophagy in Inflammatory Response against SARS-CoV-2
Roxana Resnik, Fabiana López Mingorance, Francisco Rivera, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4928-4928
Open Access | Times Cited: 10
Effects of diarylbutane lignans from Schisandra chinensis fruit on SARS-CoV-2 3CLpro and PLpro and their in vitro anti-inflammatory properties
Bin Li, Liansheng Qiao, Qi Xiao, et al.
Phytomedicine Plus (2023) Vol. 3, Iss. 2, pp. 100432-100432
Open Access | Times Cited: 10
Antiviral Effect of 5′-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection
Amanda Resende Tucci, Raquel Mello da Rosa, Alice Santos Rosa, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6696-6696
Open Access | Times Cited: 10
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411
Robert Konkel, Aleksandra Milewska, Thuc Nguyen Dan, et al.
Antiviral Research (2023) Vol. 219, pp. 105731-105731
Open Access | Times Cited: 10
Discovery of the covalent SARS‐CoV‐2 Mpro inhibitors from antiviral herbs via integrating target‐based high‐throughput screening and chemoproteomic approaches
Yani Zhang, Guanghao Zhu, Wei Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top